International Journal of Biological Markers最新文献

筛选
英文 中文
Corrigendum to Expression profile and prognostic significance of HOXB13 in rectal cancer. HOXB13在直肠癌中的表达谱和预后意义》的更正。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-02-01 DOI: 10.1177/03936155241228347
{"title":"Corrigendum to Expression profile and prognostic significance of HOXB13 in rectal cancer.","authors":"","doi":"10.1177/03936155241228347","DOIUrl":"10.1177/03936155241228347","url":null,"abstract":"","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"186"},"PeriodicalIF":2.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPRESSION OF CONCERN: 'Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer'. 表达关切:"长非编码 RNA ZEB2-AS1 的过度表达可能预示着非小细胞肺癌的不良预后,并促进肿瘤细胞的迁移、侵袭和上皮-间质转化"。
IF 2.3 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-02-23 DOI: 10.1177/03936155241231135
{"title":"EXPRESSION OF CONCERN: 'Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer'.","authors":"","doi":"10.1177/03936155241231135","DOIUrl":"10.1177/03936155241231135","url":null,"abstract":"","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"187"},"PeriodicalIF":2.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139941080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of KRT7 in bladder cancer prognosis. KRT7 在膀胱癌预后中的临床意义。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-02-06 DOI: 10.1177/03936155231224798
Jun Song, Ye Wu, Zhongming Chen, Dong Zhai, Chunpei Zhang, Shizhan Chen
{"title":"Clinical significance of KRT7 in bladder cancer prognosis.","authors":"Jun Song, Ye Wu, Zhongming Chen, Dong Zhai, Chunpei Zhang, Shizhan Chen","doi":"10.1177/03936155231224798","DOIUrl":"10.1177/03936155231224798","url":null,"abstract":"<p><strong>Background: </strong>Typically, the overexpressed keratin 7 (KRT7) is considered a validated therapeutic target and prognosis marker in bladder cancer. However, the crucial roles of KRT7 in the clinical prognosis and immune microenvironment in bladder cancer remain unclear.</p><p><strong>Methods: </strong>Initially, the expression levels of KRT7 in public databases were analyzed that is,Tumor Immune Estimation Resource (TIMER) 2.0 and Gene Expression Profiling Interactive Analysis (GEPIA). Further, the clinical tissue samples from patients (n = 10 pairs) were collected to confirm the expression trends of KRT7 and detected by immunohistochemistry (IHC) analysis. Meanwhile, the relationship between KRT7 and the prognosis of bladder cancer patients was analyzed by Kaplan-Meier plotter estimation and Cox regression analysis. Finally, TIMER 2.0 and IHC staining analyses were performed to calculate the infiltration abundances of three kinds of immune cells in eligible bladder tumor samples.</p><p><strong>Results: </strong>The TIMER 2.0 and GEPIA datasets suggested the differences in the expression levels of KRT7 in tumors, in which KRT7 was significantly upregulated in bladder cancer. The KRT7 expression was closely associated with patients' gender, tumor histologic subtypes, T status, and American Joint Committee on Cancer stages. Notably, the increased KRT7 indicated poor overall survival and disease-free survival rates. Moreover, KRT7 expression could be responsible for immune infiltration in the cancer microenvironment of the bladder. Finally, the high expression level of KRT7 increased the presence of regulatory T cells (Tregs) but reduced the infiltration of CD8+ T and natural killer cells.</p><p><strong>Conclusion: </strong>KRT7 as a biomarker potentiated the prediction of bladder cancer prognosis and the immune microenvironment.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"158-167"},"PeriodicalIF":2.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques. 通过计算技术筛选出紫外线介导的黑色素瘤的分子途径和预后生物标志物。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-02-26 DOI: 10.1177/03936155241230968
Arju Hossain, Asif Ahsan, Imran Hasan, Sohel, Arif Khan, Pratul Dipta Somadder, Sumaiya Monjur, Sipon Miah, K M Kaderi Kibria, Kawsar Ahmed, Habibur Rahman
{"title":"Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques.","authors":"Arju Hossain, Asif Ahsan, Imran Hasan, Sohel, Arif Khan, Pratul Dipta Somadder, Sumaiya Monjur, Sipon Miah, K M Kaderi Kibria, Kawsar Ahmed, Habibur Rahman","doi":"10.1177/03936155241230968","DOIUrl":"10.1177/03936155241230968","url":null,"abstract":"<p><strong>Purpose: </strong>Ultraviolet radiation causes skin cancer, but the exact mechanism by which it occurs and the most effective methods of intervention to prevent it are yet unknown. For this purpose, our study will use bioinformatics and systems biology approaches to discover potential biomarkers of skin cancer for early diagnosis and prevention of disease with applicable clinical treatments.</p><p><strong>Methods: </strong>This study compared gene expression and protein levels in ultraviolet-mediated cultured keratinocytes and adjacent normal skin tissue using RNA sequencing data from the National Center for Biotechnology Information-Gene Expression Omnibus (NCBI-GEO) database. Then, pathway analysis was employed with a selection of hub genes from the protein-protein interaction (PPI) network and the survival and expression profiles. Finally, potential clinical biomarkers were validated by receiver operating characteristic (ROC) curve analysis.</p><p><strong>Results: </strong>We identified 32 shared differentially expressed genes (DEGs) by analyzing three different subsets of the GSE85443 dataset. Skin cancer development is related to the control of several DEGs through cyclin-dependent protein serine/threonine kinase activity, cell cycle regulation, and activation of the NIMA kinase pathways. The cytoHubba plugin in Cytoscape identified 12 hub genes from PPI; among these 3 DEGs, namely, <i>AURKA, CDK4</i>, and <i>PLK1</i> were significantly associated with survival (<i>P</i> < 0.05) and highly expressed in skin cancer tissues. For validation purposes, ROC curve analysis indicated two biomarkers: <i>AURKA</i> (area under the curve (AUC) value = 0.8) and <i>PLK1</i> (AUC value = 0.7), which were in an acceptable range.</p><p><strong>Conclusions: </strong>Further translational research, including clinical experiments, teratogenicity tests, and in-vitro or in-vivo studies, will be performed to evaluate the expression of these identified biomarkers regarding the prognosis of skin cancer patients.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"118-129"},"PeriodicalIF":2.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139974269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis. 用于胆管癌鉴别诊断的新生物标记物面板:探索性分析的结果
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-03-28 DOI: 10.1177/03936155241235185
Bruno Köhler, Marta Bes, Henry Lik-Yuen Chan, Juan Ignacio Esteban, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Tawesak Tanwandee, Satawat Thongsawat, Anika Mang, David Morgenstern, Magdalena Swiatek-de Lange, Farshid Dayyani
{"title":"A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis.","authors":"Bruno Köhler, Marta Bes, Henry Lik-Yuen Chan, Juan Ignacio Esteban, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Tawesak Tanwandee, Satawat Thongsawat, Anika Mang, David Morgenstern, Magdalena Swiatek-de Lange, Farshid Dayyani","doi":"10.1177/03936155241235185","DOIUrl":"10.1177/03936155241235185","url":null,"abstract":"<p><strong>Introduction: </strong>Diagnosis of cholangiocarcinoma (CCA) can be challenging due to unclear imaging criteria and difficulty obtaining adequate tissue biopsy. Although serum cancer antigen 19-9 and carcinoembryonic antigen have been proposed as potential diagnostic aids, their use remains limited by insufficient sensitivity and specificity. This exploratory analysis aimed to identify individual- and combinations of serum biomarkers to distinguish CCA from hepatocellular carcinoma (HCC) and chronic liver disease (CLD) controls using samples from a published study.</p><p><strong>Methods: </strong>This prospective, multicenter, case-control study included patients aged ≥18 years at high-risk of HCC. Serum and ethylene diamine tetraacetic acid-plasma samples were collected prior to any treatment and confirmed diagnosis of HCC or CCA. Fourteen biomarkers (measured by electrochemiluminescence immunoassays or enzyme-linked immunosorbent assays) were subjected to univariate analysis and 13 included in a multivariate analysis (per selected combinations and exhaustive search).</p><p><strong>Results: </strong>Overall, 55 CCA, 306 HCC, and 733 CLD control samples were analyzed. For distinguishing CCA from HCC, alpha-fetoprotein and matrix metalloproteinase-2 (MMP-2) showed the best individual performance (area under the curve (AUC) 86.6% and 84.4%, respectively); tissue inhibitor of metalloproteinase-1 (TIMP-1) was most able to distinguish CCA from CLD (AUC 94.5%) and from HCC  +  CLD (AUC 88.6%). The combination of MMP-2 and TIMP-1 was the best-performing two-marker panel, with AUC >90% for all comparisons.</p><p><strong>Conclusion: </strong>MMP-2 and TIMP-1 are promising biomarkers that could support differential diagnosis of CCA. Incorporating these assays into the diagnostic algorithm could provide additional diagnostic information in a non-invasive, rapid manner, and could supplement existing diagnostic methods.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"107-117"},"PeriodicalIF":2.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of a nomogram from coagulation-related biomarkers and C1q and total bile acids in distinguishing advanced and early-stage lung cancer. 凝血相关生物标志物、C1q 和总胆汁酸提名图在区分晚期和早期肺癌中的应用。
IF 2.3 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-02-01 DOI: 10.1177/03936155241229454
Tingting Long, Xinyu Zhu, Dongling Tang, Huan Li, Pingan Zhang
{"title":"Application of a nomogram from coagulation-related biomarkers and C1q and total bile acids in distinguishing advanced and early-stage lung cancer.","authors":"Tingting Long, Xinyu Zhu, Dongling Tang, Huan Li, Pingan Zhang","doi":"10.1177/03936155241229454","DOIUrl":"10.1177/03936155241229454","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to establish a nomogram to distinguish advanced- and early-stage lung cancer based on coagulation-related biomarkers and liver-related biomarkers.</p><p><strong>Methods: </strong>A total of 306 patients with lung cancer and 172 patients with benign pulmonary disease were enrolled. Subgroup analyses based on histologic type, clinical stage, and neoplasm metastasis status were carried out and multivariable logistic regression analysis was applied. Furthermore, a nomogram model was developed and validated with bootstrap resampling.</p><p><strong>Results: </strong>The concentrations of complement C1q, fibrinogen, and D-dimers, fibronectin, inorganic phosphate, and prealbumin were significantly changed in lung cancer patients compared to benign pulmonary disease patients. Multiple regression analysis based on subgroup analysis of clinical stage showed that compared with early-stage lung cancer, female (<i>P</i> < 0.001), asymptomatic admission (<i>P</i> = 0.001), and total bile acids (<i>P</i> = 0.011) were negatively related to advanced lung cancer, while C1q (<i>P</i> = 0.038), fibrinogen (<i>P</i> < 0.001), and D-dimers (<i>P</i> = 0.001) were positively related. A nomogram model based on gender, symptom, and the levels of total bile acids, C1q, fibrinogen, and D-dimers was constructed for distinguishing advanced lung cancer and early-stage lung cancer, with an area under the receiver operating characteristic curve of 0.919. The calibration curve for this nomogram revealed good predictive accuracy (<i>P<sub>-Hosmer-Lemeshow</sub></i> = 0.697) between the predicted probability and the actual probability.</p><p><strong>Conclusions: </strong>We developed a nomogram based on gender, symptom, and the levels of fibrinogen, D-dimers, total bile acids, and C1q that can individually distinguish early- and advanced-stage lung cancer.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"130-140"},"PeriodicalIF":2.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of ANKRD13D as a potential target in renal cell carcinomas. 将 ANKRD13D 鉴定为肾细胞癌的潜在靶点。
IF 2.3 4区 医学
International Journal of Biological Markers Pub Date : 2024-06-01 Epub Date: 2024-03-06 DOI: 10.1177/03936155241236498
Wenqian Zhou, Yonghe Huang, Jing Liu, Yiguo Liu, Yuqing Liu, Chen Yu
{"title":"Identification of ANKRD13D as a potential target in renal cell carcinomas.","authors":"Wenqian Zhou, Yonghe Huang, Jing Liu, Yiguo Liu, Yuqing Liu, Chen Yu","doi":"10.1177/03936155241236498","DOIUrl":"10.1177/03936155241236498","url":null,"abstract":"<p><strong>Background: </strong>The correlation of the expression of ankyrin repeat domain (ANKRD) family members with renal cell carcinoma prognosis was investigated.</p><p><strong>Methods: </strong>The GEPIA2, GEO2R, UALCAN, GDC, OncoLnc, TIMER, PanglaoDB, CancerSEA, and Tabula Muris databases were used. Twelve ANKRD family members were identified as having overexpressed renal cell carcinoma samples. The ANKRD13D was identified as a renal cell carcinoma-specific target by cross-referencing the multiple survival databases. To clarify the role of ANKRD13D, the expression of NAKRD13D was analyzed at the single-cell level.</p><p><strong>Results: </strong>ANKRD13D was mainly expressed in immune cells and positively correlated with Treg cell infiltration. The expression of ANKRD13D was also positively correlated with PDCD1, CTLA4, LAG3, TNFSF14, and ISG20. The overexpression of ANKRD13D in Treg was confirmed using reverse transcription-quantitative polymerase chain reaction. The structure of ANKRD13D was predicted using AlphaFold.</p><p><strong>Conclusion: </strong>In conclusion, we identified ANKRD13D as a key immune regulator, and targeting ANKRD13D with immune checkpoints blockade may be a promoting strategy for renal cell carcinoma immunotherapy.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"149-157"},"PeriodicalIF":2.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas. 泛免疫炎症值在鼻咽癌同期化放疗后三联征预测中的价值
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-03-01 Epub Date: 2024-01-08 DOI: 10.1177/03936155231223198
Efsun Somay, Busra Yilmaz, Erkan Topkan, Beyza Sirin Ozdemir, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek
{"title":"Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.","authors":"Efsun Somay, Busra Yilmaz, Erkan Topkan, Beyza Sirin Ozdemir, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek","doi":"10.1177/03936155231223198","DOIUrl":"10.1177/03936155231223198","url":null,"abstract":"<p><strong>Objective: </strong>Radiation-induced trismus (RIT), one of the rare but serious side effects of concurrent chemoradiotherapy (C-CRT), is difficult to predict with high accuracy. We aimed to examine whether the pretreatment pan-immune-inflammation value (PIV) measures predict RIT in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) receiving C-CRT.</p><p><strong>Methods: </strong>Data of patients with LA-NPC who underwent C-CRT and had maximum mouth openings (MMO) > 35 mm were reviewed. Any MMO of 35 mm or less after C-CRT was considered RIT. All PIV values were computed using the complete blood count test results: PIV = (Platelets × Monocytes × Neutrophils) ÷ Lymphocytes. The receiver operating characteristic analysis was employed to dissect a possible association between pre-treatment PIV readings and RIT status. Confounding variables were tested for their independent relationship with the RIT rates using logistic regression analysis.</p><p><strong>Results: </strong>The research comprised 223 participants, and RIT was diagnosed in 46 (20.6%) at a median time from C-CRT to RIT of 10 months (range: 5-18 months). Pre-C-CRT PIV levels and RIT rates were analyzed using receiver operating characteristic curve analysis, with 830 being the optimal cutoff (area under the curve: 92.1%; sensitivity: 87.5%; specificity: 85.5%; Youden index: 0.730). RIT was significantly more prevalent in the PIV > 830 cohort than its PIV ≤ 830 counterpart (60.3% vs. 5%; hazard ratio 5.79; <i>P</i> < 0.001). Multivariate logistic regression analysis revealed that advanced T-stage (<i>P</i> = 0.004), masticatory apparatus dose V58Gy≥%32 (<i>P</i> = 0.003), and PIV > 830 (<i>P</i> < 0.001) were independently linked with significantly elevated rates of RIT.</p><p><strong>Conclusion: </strong>The presence of elevated pre-C-CRT PIV is a unique biological marker that independently predicts increased RIT rates in LA-NPC undergoing C-CRT.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"80-88"},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigation. 基于4D无标记定量蛋白质组学分析的肝细胞癌潜在预后生物标志物初步研究。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-03-01 Epub Date: 2023-11-13 DOI: 10.1177/03936155231212925
Lida Suo, Xiangnan Liang, Weibin Zhang, Mingwei Gao, Taiheng Ma, Daosheng Hu, Yilin Song, Zhenming Gao
{"title":"Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigation.","authors":"Lida Suo, Xiangnan Liang, Weibin Zhang, Mingwei Gao, Taiheng Ma, Daosheng Hu, Yilin Song, Zhenming Gao","doi":"10.1177/03936155231212925","DOIUrl":"10.1177/03936155231212925","url":null,"abstract":"<p><strong>Background: </strong>Hepatocellular carcinoma carries a poor prognosis and poses a serious threat to global health. Currently, there are few potential prognostic biomarkers available for the prognosis of hepatocellular carcinoma.</p><p><strong>Methods: </strong>This pilot study used 4D label-free quantitative proteomics to compare the proteomes of hepatocellular carcinoma and adjacent non-tumor tissue. A total of 66,075 peptides, 6363 identified proteins, and 772 differentially expressed proteins were identified in specimens from three hepatocellular carcinoma patients. Through functional enrichment analysis of differentially expressed proteins by Gene Ontology, KEGG pathway, and protein domain, we identified proteins with similar functions.</p><p><strong>Results: </strong>Twelve differentially expressed proteins (RPL17, RPL27, RPL27A, RPS5, RPS16, RSL1D1, DDX18, RRP12, TARS2, YARS2, MARS2, and NARS1) were selected for identification and validation by parallel reaction monitoring. Subsequent Western blotting confirmed overexpression of RPL27, RPS16, and TARS2 in hepatocellular carcinoma compared to non-tumor tissue in 16 pairs of clinical samples. Analysis of The Cancer Genome Atlas datasets associated the increased expression of these proteins with poor prognosis. Tissue microarray revealed a negative association between high expression of RPL27 and TARS2 and the prognosis of hepatocellular carcinoma patients, although RPS16 was not significant.</p><p><strong>Conclusions: </strong>These data suggest that RPL27 and TARS2 play an important role in hepatocellular carcinoma progression and may be potential prognostic biomarkers of overall survival in hepatocellular carcinoma patients.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"59-69"},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92157173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The value of a three-microRNA panel in serum for prostate cancer screening. 血清中三微小核糖核酸检测对前列腺癌筛查的价值。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2024-03-01 Epub Date: 2023-11-13 DOI: 10.1177/03936155231213660
Shengjie Lin, Chen Sun, Rongkang Li, Chong Lu, Xinji Li, Zhenyu Wen, Zhenjian Ge, Wenkang Chen, Yingqi Li, Hang Li, Yongqing Lai
{"title":"The value of a three-microRNA panel in serum for prostate cancer screening.","authors":"Shengjie Lin, Chen Sun, Rongkang Li, Chong Lu, Xinji Li, Zhenyu Wen, Zhenjian Ge, Wenkang Chen, Yingqi Li, Hang Li, Yongqing Lai","doi":"10.1177/03936155231213660","DOIUrl":"10.1177/03936155231213660","url":null,"abstract":"<p><strong>Background: </strong>Globally, prostate cancer is the second most common malignancy in males. Serum microRNAs (miRNAs) may function as non-invasive and innovative biomarkers for various cancers. Our study aimed to determine potential miRNAs for prostate cancer screening.</p><p><strong>Methods: </strong>A three-stage study was accomplished to ascertain crucial miRNAs as markers. In the screening stage, we searched PubMed for aberrantly expressed miRNAs relevant to prostate cancer and selected them as candidate miRNAs. In training and validation stages, with serum specimens from 112 prostate cancer patients and 112 healthy controls, expressions of candidate miRNAs were identified through quantitative reverse transcription-polymerase chain reaction. The diagnostic capabilities of miRNAs were determined by receiver operating characteristic curves. Bioinformatic analysis was utilized to explore the function of the critical miRNAs.</p><p><strong>Results: </strong>Expression of six serum miRNAs (miR-34b-3p, miR-556-5p, miR-200c-3p, miR-361-5p, miR-369-3p, miR-485-3p) were significantly altered in prostate cancer patients contrasted with healthy controls. The optimal combination of critical miRNAs is a three-miRNA panel (miR-34b-3p, miR-200c-3p, and miR-361-5p) with good diagnostic capability. FLRT2, KIAA1755, LDB3, and NTRK3 were identified as the potential genes targeted by the three-miRNA panel.</p><p><strong>Conclusions: </strong>The three-miRNA panel may perform as an innovative and promising serum marker for prostate cancer screening.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"70-79"},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92157174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信